UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells

Induction or selection of radioresistant cancer (stem) cells following standard radiotherapy is presumably one of the major causes for recurrence of metastatic disease. One possibility to prevent tumor relapse is the application of targeted immunotherapies including, e.g., chimeric antigen receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Arndt, Claudia, Loureiro, Liliana R., Feldmann, Anja, Jureczek, Justyna, Bergmann, Ralf, Máthé, Domokos, Hegedüs, Nikolett, Berndt, Nicole, Koristka, Stefanie, Mitwasi, Nicola, Fasslrinner, Frederick, Lamprecht, Chris, Kegler, Alexandra, Hoffmann, Anja, Bartsch, Tabea, Köseer, Ayşe Sedef, Egan, Gary, Schmitz, Marc, Hořejší, Vaclav, Krause, Mechthild, Dubrovska, Anna, Bachmann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219270/
https://www.ncbi.nlm.nih.gov/pubmed/32426176
http://dx.doi.org/10.1080/2162402X.2020.1743036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219270/
https://www.ncbi.nlm.nih.gov/pubmed/32426176
http://dx.doi.org/10.1080/2162402X.2020.1743036

Ejemplares similares